Uazman Alam

9.1k total citations · 3 hit papers
219 papers, 5.8k citations indexed

About

Uazman Alam is a scholar working on Physiology, Endocrinology, Diabetes and Metabolism and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Uazman Alam has authored 219 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Physiology, 53 papers in Endocrinology, Diabetes and Metabolism and 42 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Uazman Alam's work include Pain Mechanisms and Treatments (53 papers), Ocular Surface and Contact Lens (32 papers) and Botulinum Toxin and Related Neurological Disorders (32 papers). Uazman Alam is often cited by papers focused on Pain Mechanisms and Treatments (53 papers), Ocular Surface and Contact Lens (32 papers) and Botulinum Toxin and Related Neurological Disorders (32 papers). Uazman Alam collaborates with scholars based in United Kingdom, Qatar and United States. Uazman Alam's co-authors include Rayaz A. Malik, Ioannis N. Petropoulos, Daniel J. Cuthbertson, Omar Asghar, Shazli Azmi, Georgios Ponirakis, Andrew Marshall, Maryam Ferdousi, Saad Javed and Hassan Fadavi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Uazman Alam

192 papers receiving 5.7k citations

Hit Papers

Diabetic Peripheral Neuro... 2018 2026 2020 2023 2018 2021 2025 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy
    2018 335 citations Shazli Azmi, Maryam Ferdousi et al. Clinical Therapeutics profile →
  2. Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
    2021 160 citations Jamie Burgess, Maryam Ferdousi et al. profile →
  3. A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX
    2025 30 citations Matthew Anson, Sizheng Steven Zhao et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Uazman Alam 2.1k 1.3k 1.3k 1.1k 1.0k 219 5.8k
Νικόλαος Παπάνας 2.3k 1.1× 2.4k 1.8× 464 0.4× 1.2k 1.1× 300 0.3× 384 7.6k
Takeo Kato 1.3k 0.6× 1.4k 1.0× 527 0.4× 2.4k 2.2× 390 0.4× 277 8.6k
Brian C. Callaghan 3.6k 1.7× 1.5k 1.2× 268 0.2× 3.0k 2.7× 209 0.2× 178 8.4k
Giuseppe Pugliese 2.0k 0.9× 2.5k 1.9× 425 0.3× 201 0.2× 422 0.4× 200 8.8k
Nikolaοs Tentolouris 1.5k 0.7× 3.0k 2.3× 698 0.6× 329 0.3× 198 0.2× 322 7.8k
Péter Kempler 2.5k 1.2× 1.9k 1.4× 227 0.2× 1.7k 1.5× 188 0.2× 146 5.8k
Ronald M.A. Henry 1.6k 0.7× 1.7k 1.3× 863 0.7× 202 0.2× 238 0.2× 181 8.0k
Vera Bril 6.0k 2.8× 3.0k 2.3× 973 0.8× 8.4k 7.6× 830 0.8× 386 15.7k
Bruce A. Perkins 3.6k 1.7× 7.3k 5.6× 1.1k 0.9× 2.5k 2.3× 776 0.7× 253 14.4k
Massimo Porta 583 0.3× 2.1k 1.6× 237 0.2× 405 0.4× 2.3k 2.2× 184 7.0k

Countries citing papers authored by Uazman Alam

Since Specialization
Citations

This map shows the geographic impact of Uazman Alam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uazman Alam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uazman Alam more than expected).

Fields of papers citing papers by Uazman Alam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uazman Alam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uazman Alam. The network helps show where Uazman Alam may publish in the future.

Co-authorship network of co-authors of Uazman Alam

This figure shows the co-authorship network connecting the top 25 collaborators of Uazman Alam. A scholar is included among the top collaborators of Uazman Alam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uazman Alam. Uazman Alam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Zhao, Sizheng Steven, et al.. (2025). Risk of psoriatic arthritis among patients receiving apremilast versus methotrexate for psoriasis. Journal of the American Academy of Dermatology. 92(6). 1446–1448.
4.
Hughes, Michael, Barbara Ruaro, Zsuzsanna H. McMahan, et al.. (2025). Raynaud’s phenomenon is associated with an increased risk of cardiovascular disease and venous thromboembolism. Seminars in Arthritis and Rheumatism. 74. 152799–152799.
5.
6.
Lim, Jonathan, Andrew S. Williams, Jamie Burgess, et al.. (2024). Efficacy of providing energy expenditure information to guide weight loss interventions in people with obesity: A randomized controlled trial. Clinical Obesity. 15(1). e12703–e12703. 2 indexed citations
7.
Nabrdalik, Katarzyna, Yanda Meng, Hanna Kwiendacz, et al.. (2024). Artificial intelligence-based classification of cardiac autonomic neuropathy from retinal fundus images in patients with diabetes: The Silesia Diabetes Heart Study. Cardiovascular Diabetology. 23(1). 296–296. 3 indexed citations
8.
Burgess, Jamie, Christophe de Bézenac, Simon S. Keller, et al.. (2024). Brain alterations in regions associated with end‐organ diabetic microvascular disease in diabetes mellitus: A UK Biobank study. Diabetes/Metabolism Research and Reviews. 40(2). e3772–e3772. 3 indexed citations
9.
Kwiendacz, Hanna, Justyna Kulpa, Frans Coenen, et al.. (2024). Artificial intelligence‐enhanced electrocardiogram analysis for identifying cardiac autonomic neuropathy in patients with diabetes. Diabetes Obesity and Metabolism. 26(7). 2624–2633. 3 indexed citations
10.
Eleftheriadou, Aikaterini, Vincenza Spallone, Abd A. Tahrani, & Uazman Alam. (2024). Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management. Diabetologia. 67(12). 2611–2625. 13 indexed citations
11.
Anson, Matthew, David R. Riley, Gema Hernández, et al.. (2024). SGLT2 Inhibitors, but Not GLP-1 Receptor Agonists, Reduce Incidence of Gout in People Living With Type 2 Diabetes Across the Therapeutic Spectrum. Clinical Therapeutics. 46(11). 835–840. 5 indexed citations
12.
Hum, Ryan Malcolm, et al.. (2024). Metabolic syndrome and psoriatic arthritis: the role of weight loss as a disease-modifying therapy. Therapeutic Advances in Musculoskeletal Disease. 16. 1759720X241271886–1759720X241271886. 8 indexed citations
13.
Cuthbertson, Daniel J., et al.. (2023). Investigation and assessment of adrenal incidentalomas. Clinical Medicine. 23(2). 135–140. 8 indexed citations
14.
Riley, David R., Philip Austin, Gema Hernández, et al.. (2023). All‐cause mortality and cardiovascular outcomes with sodium‐glucose Co‐transporter 2 inhibitors, glucagon‐like peptide‐1 receptor agonists and with combination therapy in people with type 2 diabetes. Diabetes Obesity and Metabolism. 25(10). 2897–2909. 38 indexed citations
15.
Riley, David R., et al.. (2023). Painful Diabetic Peripheral Neuropathy: Practical Guidance and Challenges for Clinical Management. Diabetes Metabolic Syndrome and Obesity. Volume 16. 1595–1612. 27 indexed citations
16.
Dobbie, Laurence J., Bradley Pittam, Sizheng Steven Zhao, et al.. (2023). Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis. Human Reproduction. 38(6). 1168–1182. 43 indexed citations
17.
Meng, Yanda, Maryam Ferdousi, Shazli Azmi, et al.. (2023). Artificial Intelligence Based Analysis of Corneal Confocal Microscopy Images for Diagnosing Peripheral Neuropathy: A Binary Classification Model. Journal of Clinical Medicine. 12(4). 1284–1284. 16 indexed citations
18.
Alam, Uazman, Matthew Anson, Yanda Meng, et al.. (2022). Artificial Intelligence and Corneal Confocal Microscopy: The Start of a Beautiful Relationship. Journal of Clinical Medicine. 11(20). 6199–6199. 17 indexed citations
19.
Meng, Yanda, Jamie Burgess, Maryam Ferdousi, et al.. (2021). Artificial intelligence utilising corneal confocal microscopy for the diagnosis of peripheral neuropathy in diabetes mellitus and prediabetes. Diabetologia. 65(3). 457–466. 44 indexed citations
20.
Dobbie, Laurence J., Abd A. Tahrani, Uazman Alam, et al.. (2021). Exercise in Obesity—the Role of Technology in Health Services: Can This Approach Work?. Current Obesity Reports. 11(3). 93–106. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Νικόλαος Παπάνας Breakdown of academic impact, for papers by Takeo Kato Breakdown of academic impact, for papers by Brian C. Callaghan Breakdown of academic impact, for papers by Giuseppe Pugliese Breakdown of academic impact, for papers by Nikolaοs Tentolouris Breakdown of academic impact, for papers by Péter Kempler Breakdown of academic impact, for papers by Ronald M.A. Henry Breakdown of academic impact, for papers by Vera Bril Breakdown of academic impact, for papers by Bruce A. Perkins Breakdown of academic impact, for papers by Massimo Porta
Rankless by CCL
2026